Information contained in this news release is current as of the date of the press announcement, but may be subject to change without prior notice.
April 1 , 2008
Hitachi, Ltd.
Takeda Pharmaceutical Company Limited
Hitachi, Ltd. ("Hitachi") and Takeda Pharmaceutical Company Limited ("Takeda") announced today that all of Takeda’s shares of Hitachi Inspharma, Ltd. ("Hitachi Inspharma"), a joint venture which is owned by Hitachi (66%) and Takeda (34%), are transferred to Hitach on April 1, 2008.
This transfer is based on the joint venture agreement signed between Hitachi and Takeda in January 2006. Under this agreement, the transfer of shares held by Takeda to Hitachi is scheduled to take place after two years from the start of Hitachi Inspharma's commercial operation.
Established in February 2006, Hitachi Inspharma started its operation in April 2006 as an IT solution company specializing in pharmaceutical industry. Hitachi Inspharma is aiming to offer optimal and highest standard of system solution in every aspect of activities of pharmaceutical companies such as R&D, production and marketing, based on the technology, development ability and collective strength of Hitachi group, adding an IT know-how established in major players in the pharmaceutical industry.
"Outsourcing business is one of our core areas, and we are aiming at its expansion. By taking over konw-how about business system Takeda cultivated, we can establish our good position in pharmacesutical industries and succession of such know-how is expected to enable us to strengthen our business ,"said Kazuo Furukawa, Representative Executive Officer, President of Hitachi, Ltd.
"Our information system business transferred to Hitachi Inspharma has further solidified the business structure,"said Yasuchika Hasegawa, President of Takeda. "We believe Hitachi Inspharma will continue contributing to Hitachi toward the future as an IT solution company which specializing in the pharmaceutical industry."
